December 9, 2021
Hospital and physician groups on Thursday announced their plan to sue the federal government over its plan for addressing disputes about surprise medical bills, which tilts […]
December 6, 2021
Arrow International Inc, a subsidiary of Teleflex, has recalled a total of 3241 Arrow-Trerotola over-the-wire 7FR percutaneous thrombolytic device (PTD) kits because of the risk of […]
December 3, 2021
The US Food and Drug Administration yesterday approved rituximab (Rituxan) in combination with chemotherapy for pediatric patients (age 6 months to <18 years) with previously untreated, advanced stage, […]
December 1, 2021
The US Food and Drug Administration (FDA) this week approved daratumumab + hyaluronidase-fihj (Darzalex Faspro) and carfilzomib (Kyprolis) plus dexamethasone (Kd) for patients with relapsed or […]
November 30, 2021
After making a controversial change in September to a long-standing recommendation about the use of active surveillance in men with prostate cancer, the National Comprehensive Cancer […]
November 29, 2021
The US Food and Drug Administration has approved pafolacianine (Cytalux), an imaging drug indicated for use in adult patients with ovarian cancer undergoing surgery. The new […]
November 26, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The World Health Organization (WHO) on Friday classified a new COVID-19 variant […]
November 24, 2021
The US Food and Drug Administration (FDA) has approved the first treatment for post-transplant cytomegalovirus (CMV) that is resistant to other drugs. The treatment, maribavir (Livtencity), […]
November 24, 2021
For the first time, a product is available specifically for use in patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors. The product […]